Katja Lohmann1, Claire Redin2, Holger Tönnies3, Susan B Bressman4, Jose Ignacio Martin Subero3, Karin Wiegers1, Frauke Hinrichs5, Yorck Hellenbroich6, Aleksandar Rakovic1, Deborah Raymond7, Laurie J Ozelius8, Eberhard Schwinger6, Reiner Siebert9, Michael E Talkowski10, Rachel Saunders-Pullman4, Christine Klein1. 1. Institute of Neurogenetics, University Lübeck, Lübeck, Germany. 2. Center for Genomic Medicine, Massachusetts General Hospital, Boston. 3. Institute of Human Genetics, Christian-Albrechts-University, Kiel, Germany. 4. Department of Neurology, Beth Israel Medical Center, New York, New York5Department of Neurology, Albert Einstein College of Medicine, New York, New York. 5. Institute of Neurogenetics, University Lübeck, Lübeck, Germany6Institute of Human Genetics, University Lübeck, Lübeck, Germany. 6. Institute of Human Genetics, University Lübeck, Lübeck, Germany. 7. Department of Neurology, Beth Israel Medical Center, New York, New York. 8. Department of Neurology, Massachusetts General Hospital, Charlestown. 9. Institute of Human Genetics, Christian-Albrechts-University, Kiel, Germany8Institute of Human Genetics, University Hospital of Ulm, Ulm, Germany. 10. Center for Genomic Medicine, Massachusetts General Hospital, Boston7Department of Neurology, Massachusetts General Hospital, Charlestown9Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, Massachusetts.
Abstract
Importance: Chromosomal rearrangements are increasingly recognized to underlie neurologic disorders and are often accompanied by additional clinical signs beyond the gene-specific phenotypic spectrum. Objective: To elucidate the causal genetic variant in a large US family with co-occurrence of dopa-responsive dystonia as well as skeletal and eye abnormalities (ie, ptosis, myopia, and retina detachment). Design, Setting, and Participants: We examined 10 members of a family, including 5 patients with dopa-responsive dystonia and skeletal and/or eye abnormalities, from a US tertiary referral center for neurological diseases using multiple conventional molecular methods, including fluorescence in situ hybridization and array comparative genomic hybridization as well as large-insert whole-genome sequencing to survey multiple classes of genomic variations. Of note, there was a seemingly implausible transmission pattern in this family due to a mutation-negative obligate mutation carrier. Main Outcomes and Measures: Genetic diagnosis in affected family members and insight into the formation of large deletions. Results: Four members were diagnosed with definite and 1 with probable dopa-responsive dystonia. All 5 affected individuals carried a large heterozygous deletion encompassing all 6 exons of GCH1. Additionally, all mutation carriers had congenital ptosis requiring surgery, 4 had myopia, 2 had retinal detachment, and 2 showed skeletal abnormalities of the hands, ie, polydactyly or syndactyly or missing a hand digit. Two individuals were reported to be free of any disease. Analyses revealed complex chromosomal rearrangements on chromosome 14q21-22 in unaffected individuals that triggered the expansion to a larger deletion segregating with affection status. The expansion occurred recurrently, explaining the seemingly non-mendelian inheritance pattern. These rearrangements included a deletion of GCH1, which likely contributes to the dopa-responsive dystonia, as well as a deletion of BMP4 as a potential cause of digital and eye abnormalities. Conclusions and Relevance: Our findings alert neurologists to the importance of clinical red flags, ie, unexpected co-occurrence of clinical features that may point to the presence of chromosomal rearrangements as the primary disease cause. The clinical management and diagnostics of such patients requires an interdisciplinary approach in modern clinical-diagnostic care.
Importance: Chromosomal rearrangements are increasingly recognized to underlie neurologic disorders and are often accompanied by additional clinical signs beyond the gene-specific phenotypic spectrum. Objective: To elucidate the causal genetic variant in a large US family with co-occurrence of dopa-responsive dystonia as well as skeletal and eye abnormalities (ie, ptosis, myopia, and retina detachment). Design, Setting, and Participants: We examined 10 members of a family, including 5 patients with dopa-responsive dystonia and skeletal and/or eye abnormalities, from a US tertiary referral center for neurological diseases using multiple conventional molecular methods, including fluorescence in situ hybridization and array comparative genomic hybridization as well as large-insert whole-genome sequencing to survey multiple classes of genomic variations. Of note, there was a seemingly implausible transmission pattern in this family due to a mutation-negative obligate mutation carrier. Main Outcomes and Measures: Genetic diagnosis in affected family members and insight into the formation of large deletions. Results: Four members were diagnosed with definite and 1 with probable dopa-responsive dystonia. All 5 affected individuals carried a large heterozygous deletion encompassing all 6 exons of GCH1. Additionally, all mutation carriers had congenital ptosis requiring surgery, 4 had myopia, 2 had retinal detachment, and 2 showed skeletal abnormalities of the hands, ie, polydactyly or syndactyly or missing a hand digit. Two individuals were reported to be free of any disease. Analyses revealed complex chromosomal rearrangements on chromosome 14q21-22 in unaffected individuals that triggered the expansion to a larger deletion segregating with affection status. The expansion occurred recurrently, explaining the seemingly non-mendelian inheritance pattern. These rearrangements included a deletion of GCH1, which likely contributes to the dopa-responsive dystonia, as well as a deletion of BMP4 as a potential cause of digital and eye abnormalities. Conclusions and Relevance: Our findings alert neurologists to the importance of clinical red flags, ie, unexpected co-occurrence of clinical features that may point to the presence of chromosomal rearrangements as the primary disease cause. The clinical management and diagnostics of such patients requires an interdisciplinary approach in modern clinical-diagnostic care.
Authors: S B Bressman; D Raymond; K Wendt; R Saunders-Pullman; D De Leon; S Fahn; L Ozelius; N Risch Journal: Neurology Date: 2002-12-10 Impact factor: 9.910
Authors: Harrison Brand; Ryan L Collins; Carrie Hanscom; Jill A Rosenfeld; Vamsee Pillalamarri; Matthew R Stone; Fontina Kelley; Tamara Mason; Lauren Margolin; Stacey Eggert; Elyse Mitchell; Jennelle C Hodge; James F Gusella; Stephan J Sanders; Michael E Talkowski Journal: Am J Hum Genet Date: 2015-06-18 Impact factor: 11.025
Authors: Michael E Talkowski; Zehra Ordulu; Vamsee Pillalamarri; Carol B Benson; Ian Blumenthal; Susan Connolly; Carrie Hanscom; Naveed Hussain; Shahrin Pereira; Jonathan Picker; Jill A Rosenfeld; Lisa G Shaffer; Louise E Wilkins-Haug; James F Gusella; Cynthia C Morton Journal: N Engl J Med Date: 2012-12-06 Impact factor: 91.245
Authors: Preeti Bakrania; Maria Efthymiou; Johannes C Klein; Alison Salt; David J Bunyan; Alex Wyatt; Chris P Ponting; Angela Martin; Steven Williams; Victoria Lindley; Joanne Gilmore; Marie Restori; Anthony G Robson; Magella M Neveu; Graham E Holder; J Richard O Collin; David O Robinson; Peter Farndon; Heidi Johansen-Berg; Dianne Gerrelli; Nicola K Ragge Journal: Am J Hum Genet Date: 2008-01-31 Impact factor: 11.025
Authors: Alba Sanchis-Juan; Jonathan Stephens; Courtney E French; Nicholas Gleadall; Karyn Mégy; Christopher Penkett; Olga Shamardina; Kathleen Stirrups; Isabelle Delon; Eleanor Dewhurst; Helen Dolling; Marie Erwood; Detelina Grozeva; Luca Stefanucci; Gavin Arno; Andrew R Webster; Trevor Cole; Topun Austin; Ricardo Garcia Branco; Willem H Ouwehand; F Lucy Raymond; Keren J Carss Journal: Genome Med Date: 2018-12-07 Impact factor: 11.117